docetaxel nordic 20 mg/ml infuusiokonsentraatti, liuosta varten
nordic group b.v. - docetaxel - infuusiokonsentraatti, liuosta varten - 20 mg/ml - dosetakseli
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - mahalaukun kasvaimet - antineoplastiset aineet - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
trasylol 10000 kiu/ml injektio-/infuusioneste, liuos
nordic group b.v. - aprotinine - injektio-/infuusioneste, liuos - 10000 kiu/ml - aprotiniini
artzal 10 mg/ml injektioneste, liuos
nordic drugs ab - natrii hyaluronas - injektioneste, liuos - 10 mg/ml - hyaluronihappo
tradil 200 mg tabletti, kalvopäällysteinen
nordic drugs ab - dexibuprofenum - tabletti, kalvopäällysteinen - 200 mg - deksibuprofeeni
tradil 300 mg tabletti, kalvopäällysteinen
nordic drugs ab - dexibuprofenum - tabletti, kalvopäällysteinen - 300 mg - deksibuprofeeni
tradil 400 mg tabletti, kalvopäällysteinen
nordic drugs ab - dexibuprofenum - tabletti, kalvopäällysteinen - 400 mg - deksibuprofeeni
gardex 10 mg tabletti, kalvopäällysteinen
nordic drugs ab - cetirizini dihydrochloridum - tabletti, kalvopäällysteinen - 10 mg - setiritsiini
deflazacort vital pharma nordic 30 mg tabletti
vital pharma nordic aps - deflazacort - tabletti - 30 mg - deflatsakorti
deflazacort vital pharma nordic 6 mg tabletti
vital pharma nordic aps - deflazacort - tabletti - 6 mg - deflatsakorti